Warning: The NCBI web site requires JavaScript to function. more...
Altered fractalkine cleavage results in an organ-specific 17 kDa fractalkine fragment in salivary glands of NOD mice.
Delaleu N, Jonsson R.
Arthritis Res Ther. 2008;10(4):114. Epub 2008 Jul 31.
Related citations
Altered fractalkine cleavage potentially promotes local inflammation in NOD salivary gland.
Wildenberg ME, van Helden-Meeuwsen CG, Drexhage HA, Versnel MA.
Arthritis Res Ther. 2008;10(3):R69. Epub 2008 Jun 19.
The role of fractalkine as an accelerating factor on the autoimmune exocrinopathy in mice.
Tsubota K, Nishiyama T, Mishima K, Inoue H, Doi T, Hattori Y, Kodama T, Higuchi A, Hayashi Y, Saito I.
Invest Ophthalmol Vis Sci. 2009 Oct;50(10):4753-60. Epub 2009 Apr 30.
E2F-1-deficient NOD/SCID mice developed showing decreased saliva production.
Matsui-Inohara H, Uematsu H, Narita T, Satoh K, Yonezawa H, Kuroda K, Ito T, Yoneda S, Kawarai T, Sugiya H, Watanabe H, Senpuku H.
Exp Biol Med (Maywood). 2009 Dec;234(12):1525-36.
Salivary gland changes in the NOD mouse model for Sjögren's syndrome: is there a non-immune genetic trigger?
Humphreys-Beher MG, Yamachika S, Yamamoto H, Maeda N, Nakagawa Y, Peck AB, Robinson CP.
Eur J Morphol. 1998 Aug;36 Suppl:247-51.
Impaired salivary gland function in NOD mice: association with changes in cytokine profile but not with histopathologic changes in the salivary gland.
Jonsson MV, Delaleu N, Brokstad KA, Berggreen E, Skarstein K.
Arthritis Rheum. 2006 Jul;54(7):2300-5.
Protein kinase C expression in salivary gland acinar epithelial cells in non-obese diabetic mice, an experimental model for Sjögren's syndrome.
Tensing EK, Ma J, Hukkanen M, Fox HS, Li TF, Törnwall J, Konttinen YT.
Rheumatol Int. 2005 Jan;25(1):28-32. Epub 2003 Sep 12.
Two NOD Idd-associated intervals contribute synergistically to the development of autoimmune exocrinopathy (Sjögren's syndrome) on a healthy murine background.
Cha S, Nagashima H, Brown VB, Peck AB, Humphreys-Beher MG.
Arthritis Rheum. 2002 May;46(5):1390-8.
Blockade of lymphotoxin-beta receptor signaling reduces aspects of Sjögren's syndrome in salivary glands of non-obese diabetic mice.
Gatumu MK, Skarstein K, Papandile A, Browning JL, Fava RA, Bolstad AI.
Arthritis Res Ther. 2009;11(1):R24. Epub 2009 Feb 18.
New concepts for the development of autoimmune exocrinopathy derived from studies with the NOD mouse model.
Humphreys-Beher MG, Peck AB.
Arch Oral Biol. 1999 May;44 Suppl 1:S21-5. Review.
The role of caspase cascade on the development of primary Sjögren's syndrome.
Hayashi Y, Arakaki R, Ishimaru N.
J Med Invest. 2003 Feb;50(1-2):32-8. Review.
Immunization with short peptides from the 60-kDa Ro antigen recapitulates the serological and pathological findings as well as the salivary gland dysfunction of Sjogren's syndrome.
Scofield RH, Asfa S, Obeso D, Jonsson R, Kurien BT.
J Immunol. 2005 Dec 15;175(12):8409-14.
Fas (APO-1/CD95)-assisted suicide in NOD exocrine glands.
Elkon KB.
Clin Exp Rheumatol. 1998 Nov-Dec;16(6):659-61. Review. No abstract available.
Assessment of bromhexine as a treatment regimen in Sjögren's syndrome-like disease in the NOD (non-obese diabetic) mouse.
Nanni JM, Nguyen KH, Alford CE, Robinson CP, Stewart CM, Maeda N, Humphreys-Beher MG.
Clin Exp Rheumatol. 1997 Sep-Oct;15(5):515-21.
Vasoactive intestinal peptide inhibits TNF-alpha-induced apoptotic events in acinar cells from nonobese diabetic mice submandibular glands.
Calafat M, Larocca L, Roca V, Hauk V, Pregi N, Nesse A, Pérez Leirós C.
Arthritis Res Ther. 2009;11(2):R53. Epub 2009 Apr 8.
Biomarker profiles in serum and saliva of experimental Sjögren's syndrome: associations with specific autoimmune manifestations.
Delaleu N, Immervoll H, Cornelius J, Jonsson R.
Arthritis Res Ther. 2008;10(1):R22. Epub 2008 Feb 20.
Elevated levels of cysteine protease activity in saliva and salivary glands of the nonobese diabetic (NOD) mouse model for Sjögren syndrome.
Robinson CP, Yamachika S, Alford CE, Cooper C, Pichardo EL, Shah N, Peck AB, Humphreys-Beher MG.
Proc Natl Acad Sci U S A. 1997 May 27;94(11):5767-71.
Defective signalling in salivary glands precedes the autoimmune response in the non-obese diabetic mouse model of sialadenitis.
Rosignoli F, Roca V, Meiss R, Leceta J, Gomariz RP, Pérez Leirós C.
Clin Exp Immunol. 2005 Dec;142(3):411-8.
A dual role for interferon-gamma in the pathogenesis of Sjogren's syndrome-like autoimmune exocrinopathy in the nonobese diabetic mouse.
Cha S, Brayer J, Gao J, Brown V, Killedar S, Yasunari U, Peck AB.
Scand J Immunol. 2004 Dec;60(6):552-65.
Development of Sjogren's syndrome in nonobese diabetic-derived autoimmune-prone C57BL/6.NOD-Aec1Aec2 mice is dependent on complement component-3.
Nguyen CQ, Kim H, Cornelius JG, Peck AB.
J Immunol. 2007 Aug 15;179(4):2318-29.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on